Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8212946 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 35 Pages |
Abstract
HRCaP treated with EBRT, LDR, or RP yields efficacy showing better bRFS for LDR and EBRT relative to RP, equivalence for cRFS, and a PCSM advantage of LDR and RP over EBRT. The toxicity is lowest for LDR.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jay P. MD, Michael MD, Chandana A. MS, Jeffrey MD, Harguneet Singh, Rahul MD, Kevin L. MD, James MD, Kenneth MD, Andrew MD, Steven MD, Georges-Pascal MD, PhD, Eric A. MD,